News and Trends 13 Nov 2017
Spanish Biotech Gets €2.4M to Spot Myocardial Infarction Before it’s Too Late
GlyCardial Diagnostics believes it has the technology to prevent premature myocardial infarctions, 80% of which are preventable. Barcelona-based GlyCardial Diagnostics is a biotech, which spun-out from the Catalan Institute of Cardiovascular…